483 Eli Lilly and Company Jan 2008

483 Eli Lilly and Company Jan 2008

Ernest Bizjak FDA, Rebecca Dombrowski FDA, Patsy Domingo FDA, Tina Pawlowski FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly and Company - Indianapolis, IN, United States facility and issued inspectional observations (via FDA 483) on 31 Jan 2008.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Jan 2008
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart